List of Excipients in API CYCLOBENZAPRINE HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing CYCLOBENZAPRINE HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | 0093-1920 | D&C YELLOW NO. 10 | |
| Teva Pharmaceuticals USA Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | 0093-1920 | DIETHYL PHTHALATE | |
| Teva Pharmaceuticals USA Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | 0093-1920 | ETHYLCELLULOSE | |
| Teva Pharmaceuticals USA Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | 0093-1920 | FD&C GREEN NO. 3 | |
| Teva Pharmaceuticals USA Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | 0093-1920 | FD&C RED NO. 40 | |
| Teva Pharmaceuticals USA Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | 0093-1920 | GELATIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing CYCLOBENZAPRINE HYDROCHLORIDE
Detailed excipient profiles for CYCLOBENZAPRINE HYDROCHLORIDE
Excipient focus: ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | cyclobenzaprine hydrochloride | 66116-527 |
| RedPharm Drug Inc | cyclobenzaprine hydrochloride | 67296-0106 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ANHYDROUS LACTOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing BUTYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | cyclobenzaprine hydrochloride | 50436-0950 |
| Quality Care Products LLC | cyclobenzaprine hydrochloride | 55700-726 |
| Casper Pharma LLC | cyclobenzaprine hydrochloride | 70199-014 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CARNAUBA WAX
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing CARNAUBA WAX
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | cyclobenzaprine hydrochloride | 16590-544 |
| STAT Rx USA LLC | cyclobenzaprine hydrochloride | 42549-641 |
| State of Florida DOH Central Pharmacy | cyclobenzaprine hydrochloride | 53808-1039 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing CROSCARMELLOSE SODIUM
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing CROSPOVIDONE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing D&C YELLOW NO. 10
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: DIETHYL PHTHALATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing DIETHYL PHTHALATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing DIETHYL PHTHALATE
Excipient focus: ETHYLCELLULOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ETHYLCELLULOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSES
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | cyclobenzaprine hydrochloride | 16590-596 |
| Rebel Distributors Corp | cyclobenzaprine hydrochloride | 21695-723 |
| Rebel Distributors Corp | cyclobenzaprine hydrochloride | 21695-953 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 1
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 62332-646 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C GREEN NO. 3
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FD&C GREEN NO. 3
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 40
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FD&C RED NO. 40
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FD&C YELLOW NO. 6
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FERRIC OXIDE RED
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FERRIC OXIDE YELLOW
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing FERROSOFERRIC OXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing GELATIN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing GELATIN
Excipient focus: HYDROXYPROPYL CELLULOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYDROXYPROPYL CELLULOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYPROMELLOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | cyclobenzaprine hydrochloride | 69336-104 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYPROMELLOSE 2910
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 16070722
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYPROMELLOSE ACETATE SUCCINATE 16070722
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 16070722
Excipient focus: HYPROMELLOSES
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing HYPROMELLOSES
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing ISOPROPYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing LACTOSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing LACTOSE MONOHYDRATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing LECITHIN, SOYBEAN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing MAGNESIUM STEARATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing METHYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing METHYL ALCOHOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing MICROCRYSTALLINE CELLULOSE 102
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POLYDEXTROSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 0378-0771 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 1000
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Sterling Knight PharmaceuticalsLLC | cyclobenzaprine hydrochloride | 69336-104 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 1000
Excipient focus: POLYETHYLENE GLYCOL 1450
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 1450
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 62332-646 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 1450
Excipient focus: POLYETHYLENE GLYCOL 400
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 400
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOL 8000
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYETHYLENE GLYCOLS
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYSORBATE 80
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POLYVINYL ALCOHOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POTASSIUM HYDROXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POTASSIUM HYDROXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing PROPYLENE GLYCOL
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing SHELLAC
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing SILICON DIOXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | cyclobenzaprine hydrochloride | 60505-3972 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 0378-0771 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing STARCH, CORN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Medsource Pharmaceuticals | cyclobenzaprine hydrochloride | 45865-685 |
| DIRECT RX | cyclobenzaprine hydrochloride | 61919-025 |
| Ranbaxy Pharmaceuticals Inc | cyclobenzaprine hydrochloride | 63304-214 |
| >Company | >Ingredient | >NDC |
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: SUCROSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing SUCROSE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing SUCROSE
Excipient focus: TALC
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing TALC
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing TITANIUM DIOXIDE
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants containing TRIACETIN
CYCLOBENZAPRINE HYDROCHLORIDE drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
